Post–Covid-19 Cholangiopathy—A New Indication for Liver Transplantation: A Case Report
Authors:
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 53 (4) , 1132-1137
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Trigger mechanisms of secondary sclerosing cholangitis in critically ill patientsCritical Care, 2015
- Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experienceFrontiers of Medicine, 2014
- Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDSEuropean Journal of Medical Research, 2012
- Secondary sclerosing cholangitis in critically ill patients: Model of End-Stage Liver Disease score and renal function predict outcomeEndoscopy, 2012
- The Biliary HCO3 − Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing CholangiopathiesHepatology, 2010
- Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosisVirchows Archiv, 2008
- Poor outcome in progressive sclerosing cholangitis after septic shockEndoscopy, 2008
- Ischemic-Like Cholangiopathy With Secondary Sclerosing Cholangitis in Critically Ill PatientsAmerican Journal of Gastroenterology, 2007
- Ischemic cholangiopathyJournal of Hepatology, 2006
- Epinephrine impairs splanchnic perfusion in septic shockCritical Care Medicine, 1997